Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00391235 · ClinicalTrials.gov registry record
White Matter in Pediatric Bipolar Disorder: A DTI Study
A clinical trial, sponsored by Cambridge Health Alliance.
- Completed
- Registry status
- 28
- Enrollment target
NCT00391235: Completed study, sponsored by Cambridge Health Alliance.
NCT00391235 is a clinical trial that has completed, run by Cambridge Health Alliance. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00391235 has completed, sponsored by Cambridge Health Alliance.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
Fourteen subjects with bipolar disorder and 14 matching healthy controls, aged 6-13, will receive a magnetic resonance imaging (MRI) scan on a 3 Tesla scanner. They will also have a clinical interview, including the KSADS-PL. All subjects must be right-handed.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2005-09 |
| Est. Completion | 2008-10 |
What the finished NCT00391235 record still lists
NCT00391235 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00391235 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00391235 about?
NCT00391235 is a clinical study titled "White Matter in Pediatric Bipolar Disorder: A DTI Study". Fourteen subjects with bipolar disorder and 14 matching healthy controls, aged 6-13, will receive a magnetic resonance imaging (MRI) scan on a 3 Tesla scanner. They will also have a clinical interview, including the KSADS-PL. All subjects must be right-handed.
What is the current status of trial NCT00391235?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2005-09. Estimated completion is 2008-10.
Who is sponsoring clinical trial NCT00391235?
This trial is sponsored by Cambridge Health Alliance, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia